Biomarin Pharmaceutical (BMRN) Times Interest Earned (2017 - 2025)
Historic Times Interest Earned for Biomarin Pharmaceutical (BMRN) over the last 16 years, with Q3 2025 value amounting to -$18.1.
- Biomarin Pharmaceutical's Times Interest Earned fell 14718.0% to -$18.1 in Q3 2025 from the same period last year, while for Sep 2025 it was $57.53, marking a year-over-year increase of 16601.96%. This contributed to the annual value of $38.23 for FY2024, which is 25672.76% up from last year.
- Per Biomarin Pharmaceutical's latest filing, its Times Interest Earned stood at -$18.1 for Q3 2025, which was down 14718.0% from $103.35 recorded in Q2 2025.
- In the past 5 years, Biomarin Pharmaceutical's Times Interest Earned registered a high of $103.35 during Q2 2025, and its lowest value of -$18.1 during Q3 2025.
- Over the past 5 years, Biomarin Pharmaceutical's median Times Interest Earned value was $10.15 (recorded in 2022), while the average stood at $20.57.
- In the last 5 years, Biomarin Pharmaceutical's Times Interest Earned skyrocketed by 166370.63% in 2023 and then plummeted by 14718.0% in 2025.
- Quarter analysis of 5 years shows Biomarin Pharmaceutical's Times Interest Earned stood at -$17.13 in 2021, then skyrocketed by 78.93% to -$3.61 in 2022, then skyrocketed by 223.94% to $4.47 in 2023, then soared by 1300.13% to $62.63 in 2024, then crashed by 128.91% to -$18.1 in 2025.
- Its Times Interest Earned stands at -$18.1 for Q3 2025, versus $103.35 for Q2 2025 and $78.2 for Q1 2025.